Metformin changes the immune microenvironment of colorectal cancer in patients with type 2 diabetes mellitus

Accumulating evidence suggests that metformin reduces the incidence and mortality of colorectal cancer (CRC). However, underlying mechanisms have not been fully clarified. The aim of this study was to examine the pathological characteristics of resected CRC from patients treated with metformin for t...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancer Sci
Asıl Yazarlar: Saito, Akira, Kitayama, Joji, Horie, Hisanaga, Koinuma, Koji, Ohzawa, Hideyuki, Yamaguchi, Hironori, Kawahira, Hiroshi, Mimura, Toshiki, Lefor, Alan Kawarai, Sata, Naohiro
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2020
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7648042/
https://ncbi.nlm.nih.gov/pubmed/32794612
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14615
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller